4 ms·
Peter Thiel has quietly become mainly focused on biotech. Most of his board seats are biotech companies, including a few he supported through going public. This
by rogerkirkness 3y ago
Peter Thiel has quietly become mainly focused on biotech. Most of his board seats are biotech companies, including a few he supported through going public. This investment makes more sense in the context of Peter as pre IPO biotech specialist.
- dekhn 3y agobut thiel isn't a biotech specialist. He's a dilettante.
- catchnear4321 3y agodon’t you mean future flesh host to the machine god? it’s fine. it’s basically the same thing at this point.
- neets 3y agoThat may be the funniest thing I have ever read on hacker news
- not_your_vase 3y agoSure, it makes sense for Thiel. It doesn't seem to make sense for Musk.